$SDEV

SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly Novabay Pharmaceuticals, Inc.) Stockholders

GlobeNewswire Inc. · 8/4/2026, 3:50:00 AM

Abbott Cooper PLLC is investigating potential fiduciary duty breaches by the board of directors of Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.). The investigation targets stockholders who continuously held shares since prior to August 19, 2025. Similar investigations are also underway for Kalaris Therapeutics (formerly AlloVir) and Abundia Global Impact Group (formerly Houston American Energy Corp.).

AGIG: Abbott Cooper PLLC Announces Investigation on Behalf of Abundia Global Impact Group, Inc. (Formerly Houston American Energy Corp.) Stockholders

GlobeNewswire Inc. · 7/9/2026, 3:06:00 AM

Abbott Cooper PLLC has announced investigations into potential fiduciary duty violations and wrongdoing by the boards of directors of three companies: Abundia Global Impact Group, Inc. (formerly Houston American Energy Corp.), Estrella Immunopharma, Inc., and Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.). The law firm is seeking stockholders who held shares continuously since July 1, 2025, or earlier to join the investigations on a contingency fee basis.

SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly NovaBay Pharmaceuticals, Inc.) Stockholders

GlobeNewswire Inc. · 6/18/2026, 3:22:00 AM

Abbott Cooper PLLC is investigating potential fiduciary duty violations by the Board of Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.) in connection with a private placement of preferred stock. The investigation targets stockholders who held shares prior to August 19, 2025.